MDT-ERAS与常规ERAS在机器人胰十二指肠切除术围术期中的应用效果对比研究
A Comparative Study on the Application Effects of MDT-ERAS and Conventional ERAS in the Perioperative Period of Robotic Pancreaticoduodenectomy
未经授权,不得转载,摘编本刊文章,不得使用本刊的版式设计。
申明:本刊刊出的所有文章不代表本刊主办单位和编委会的观点。
-
摘要:目的 对比多学科协作(multidisciplinary team,MDT)模式下的加速康复外科(enhanced recovery after surgery,MDT-ERAS)与常规ERAS在机器人胰十二指肠切除术(robotic pancreaticoduodenectomy,RPD)患者围术期中的应用效果。方法 回顾性分析2021年5月至2024年12月在广东省人民医院胰腺中心接受RPD的72例患者临床资料,其中MDT-ERAS组30例,常规ERAS组42例。比较两组患者术后首次进食、首次下床、首次排气和排便时间、住院时间、住院费用、疼痛评分、焦虑抑郁评分、生存质量及术后并发症情况。结果 两组患者的术后首次进食时间、首次下床时间、首次排气排便时间、住院时间、住院费用、疼痛评分、焦虑抑郁评分、生存质量评分,MDT组患者均低于匹配组,差异有统计学意义(P<0.05);术后并发症对比无统计学意义(P>0.05)。结论 MDT-ERAS在机器人胰十二指肠切除术围术期中的应用效果明显优于常规ERAS,有助于促进胃肠功能恢复、减少术后疼痛、缓解术后焦虑抑郁、缩短患者住院时间、减少住院费用,从而提高患者生存质量,并发症的发生率无明显区别。Abstract:Objective To compare the perioperative outcomes of multidisciplinary team–enhanced recovery after surgery (MDT-ERAS) versus conventional ERAS in patients undergoing robotic pancreaticoduodenectomy (RPD).Methods A retrospective analysis was performed on 72 patients who underwent RPD at the Pancreatic Center of Guangdong Provincial People's Hospital from May 2021 to December 2024. Thirty patients received MDT-ERAS (MDT group) and 42 patients received conventional ERAS (control group). Perioperative outcomes, including time to first feeding, ambulation, flatus and defecation, length of hospital stay, hospitalization costs, pain scores, anxiety and depression scores, quality of life, and postoperative complications, were compared between the two groups.Results Compared with the control group, the MDT group showed significantly shorter times to first feeding, ambulation, flatus and defecation, as well as reduced length of stay, lower hospitalization costs, lower pain and anxiety/depression scores, and higher quality-of-life scores (all P < 0.05). The incidence of postoperative complications did not differ significantly between the two groups (P > 0.05).Conclusion MDT-ERAS demonstrates significantly superior perioperative outcomes compared with conventional ERAS in patients undergoing robotic pancreaticoduodenectomy. It facilitates gastrointestinal function recovery, reduces postoperative pain, alleviates anxiety and depression, shortens hospital stay, lowers hospitalization costs, and thereby improves patients’ quality of life, while showing no significant difference in the incidence of complications.
下载: